ReleaseWire

Banyan Biomarkers (Banyan) is a pharmaceutical and healthcare company, based in the US. It develops and markets biomarker diagnostic tests for the in-vitro diagnostic markets. The company’s research has identified unique and proprietary biomarkers present in the patient’s blood following injury to the brain. It provides insight into the brain and enlightenment for those seeking to cure its various ailments. The company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuro inflammation/microglial activation, apoptosis, necrosis, and liver injuries/hepatoxicity, biomarkers for stroke, alzheimer’s disease, parkinson’s and huntington’s disease, and depression. Banyan is headquartered in Alachua, Florida, the US.

Vivacta Limited (Vivacta) is a privately held medical diagnostic company, based in the UK. It develops and markets point-care tests for the in-vitro diagnostic markets. The company's piezofilm detection technology has benefits in the quantization of binding reactions such as immunoassays and gene probe assays. Its immunoassay tests detect a binding event between the target molecule (antigen) and antibodies. Vivacta develops diagnostic system, which consists of a low cost generic instrument (the Reader), and single use cartridge tests such as piezofilm sensor (the Cartridge). Its research and development wing concentrates on developing new technologies and products. Vivacta is headquartered in Sittingbourne, Kent, the UK.

A huge amount of speakers are sold every year, and with the popularity of home cinema systems there have been even more purchases in recent years. However it seems like even though more people are looking to buy speakers, the prices just keep going up.

Taking responsibility for finances involves tasks like paying the bills and creating a budget, but it also includes understanding how savings accounts and money markets work and becoming aware of fluctuating rates that can impact financial futures. Without this knowledge and information, it can be difficult to effectively save or invest and know the best options for keeping money protected.

W2 and 1099 software provider, Halfpricesoft.com, released the improved version of ezW2 software for Year 2012 tax season. This new edition can support W2 & 1099 preparing, printing and e-filing. It also helps users cut cost on the red-ink forms.

Car Loans Australia is pleased to announce the launch of their fully redesigned new website CarLoansAustralia.com.au. Car Loans Australia has been providing the best car finance and car loan packages throughout Australia for the last five years.

Having diligently served with Blackwater in Baghdad, Tim Beckman’s new book offers a frankly honest and exclusive insight into the work of the often-contentious protective services contractor in Iraq.

ReportReserve’s pharmaceuticals report, “Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Achillion Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Addex Therapeutics - Product Pipeline Review - 2012” provides data on the Addex Therapeutics’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Adherex Technologies Inc. - Product Pipeline Review - 2012” provides data on the Adherex Technologies Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Novo Nordisk A/S - Product Pipeline Review - 2012” provides data on the Novo Nordisk A/S’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “SciClone Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the SciClone Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Targa Therapeutics Corp. - Product Pipeline Review - 2012” provides data on the Targa Therapeutics Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Telik, Inc. - Product Pipeline Review - 2012” provides data on the Telik, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Wockhardt Limited - Product Pipeline Review - 2012” provides data on the Wockhardt Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Zalicus Inc. - Product Pipeline Review - 2012” provides data on the Zalicus Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ReportReserve’s pharmaceuticals report, “Actelion Ltd - Product Pipeline Review - 2012” provides data on the Actelion Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.